Advertisement

Hypertension in Moderate-to-Severe Nondiabetic CKD Patients

  • Julian Segura
    Affiliations
    Hypertension Unit, Madrid & Cátedra de Prevención de Enfermedad Cardiovascular, Hospital 12 de Octubre, Universidad Autónoma, Madrid, Spain
    Search for articles by this author
  • Luis M. Ruilope
    Correspondence
    Address correspondence to Luis M Ruilope, MD, PhD, Hypertension Unit, Madrid & Cátedra de Prevención de Enfermedad Cardiovascular, Hospital 12 de Octubre, Universidad Autónoma, Av. Córdoba s/n, 28041 Madrid, Spain.
    Affiliations
    Hypertension Unit, Madrid & Cátedra de Prevención de Enfermedad Cardiovascular, Hospital 12 de Octubre, Universidad Autónoma, Madrid, Spain
    Search for articles by this author
      High blood pressure can be both a cause and a consequence of chronic kidney disease and will contribute to an unfavorable renal and cardiovascular (CV) prognosis. Both in the general population and in hypertensive patients, the presence of chronic kidney disease is associated with a high prevalence of CV disease. Elevated blood pressure and the amount of albumin present in urine are the 2 most relevant factors facilitating the progression of chronic kidney disease in hypertensive patients. Therapeutic attitudes that must be considered when chronic kidney disease is present include the simultaneous performance of CV and renal protection.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Chronic Kidney Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bakris G.L.
        • Ritz E.
        • World Kidney Day Steering Committee World CKD Day
        The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.
        Clin J Am Soc Nephrol. 2009; 4: 517-519
        • Kearney P.M.
        • Whelton M.
        • Reynolds K.
        • et al.
        Global burden of hypertension: analysis of worldwide data.
        Lancet. 2005; 365: 217-223
        • Ruilope L.M.
        • Lahera V.
        • Rodicio J.L.
        • et al.
        Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans?.
        Hypertension. 1994; 23: 3-9
        • Sarnak M.J.
        • Levey A.S.
        • Schoolwerth A.C.
        • et al.
        Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention.
        Circulation. 2003; 108: 2154-2169
        • Bakris G.L.
        Protecting renal function in the hypertensive patient: clinical guidelines.
        Am J Hypertens. 2005; 18: 112S-119S
        • Egan B.M.
        • Zhao Y.
        • Axon R.N.
        US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.
        JAMA. 2010; 303: 2043-2050
        • Wolf-Maier K.
        • Cooper R.S.
        • Banegas J.R.
        • et al.
        Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.
        JAMA. 2003; 289: 2363-2369
        • Peralta C.A.
        • Hicks L.S.
        • Chertow G.M.
        • et al.
        Control of hypertension in adults with chronic kidney disease in the United States.
        Hypertension. 2005; 45: 1119-1124
        • Sarafidis P.A.
        • Li S.
        • Chen S.C.
        • et al.
        Hypertension awareness, treatment, and control in chronic kidney disease.
        Am J Med. 2008; 121: 332-340
        • Muntner P.
        • Anderson A.
        • Charleston J.
        • et al.
        • Chronic Renal Insufficiency Cohort (CRIC) study investigators
        Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
        Am J Kidney Dis. 2010; 55: 441-451
        • Culleton B.F.
        • Larson M.G.
        • Wilson P.W.F.
        • et al.
        Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency.
        Kidney Int. 1999; 56: 2214-2219
        • Coresh J.
        • Astor B.C.
        • Greene T.
        • et al.
        Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey.
        Am J Kidney Dis. 2003; 41: 1-12
        • Coresh J.
        • Selvin E.
        • Stevens L.A.
        • et al.
        Prevalence of chronic kidney disease in the United States.
        JAMA. 2007; 298: 2038-2047
        • Levey A.S.
        • Atkins R.
        • Coresh J.
        • et al.
        Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from kidney disease improving global outcomes.
        Kidney Int. 2007; 72: 247-259
        • Segura J.
        • Campo C.
        • Ruilope L.M.
        How relevant and frequent is the presence of mild renal insufficiency in essential hypertension?.
        J Clin Hypertens (Greenwich). 2002; 4: 332-336
        • Kendrick J.
        • Chonchol M.B.
        Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
        Nat Clin Pract Nephrol. 2008; 4: 672-681
        • Coca S.G.
        • Krumholz H.M.
        • Garg A.X.
        • Parikh C.R.
        Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.
        JAMA. 2006; 296: 1377-1384
        • Ruilope L.M.
        • Salvetti A.
        • Jamerson K.
        • et al.
        Renal function and intensive lowering of blood pressure in the hypertensive subjects of the Hypertension Optimal Treatment (HOT) Study.
        J Am Soc Nephrol. 2001; 12: 218-225
        • Rahman M.
        • Pressel S.
        • Davis B.R.
        • et al.
        • ALLHAT Collaborative Research Group
        Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic.
        Arch Intern Med. 2005; 165: 936-946
        • Bakris G.L.
        • Sarafidis P.A.
        • Weir M.R.
        • et al.
        • for the ACCOMPLISH trial investigators
        Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
        Lancet. 2010; 375: 1173-1181
        • de Leeuw P.W.
        • Ruilope L.M.
        • Palmer C.R.
        • et al.
        Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial.
        Arch Intern Med. 2004; 164: 2459-2464
        • Mann J.F.E.
        • Gerstein H.C.
        • Pogue J.
        • et al.
        Renal insufficiency as predictor of cardiovascular outcomes and impact of ramipril: the HOPE randomization trial.
        Ann Intern Med. 2001; 134: 629-636
        • Mann J.F.E.
        • Schmieder R.E.
        • McQueen M.
        • et al.
        • ONTARGET investigators
        Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
        Lancet. 2008; 372: 547-553
        • Ruilope L.M.
        • Zanchetti A.
        • Julius S.
        • et al.
        • VALUE investigators
        Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial.
        J Hypertens. 2007; 25: 1473-1479
        • Banegas J.R.
        • Segura J.
        • Ruilope L.M.
        • et al.
        • CLUE study group investigators
        Blood pressure control and physician management of hypertension in hospital hypertension units in Spain.
        Hypertension. 2004; 43: 1338-1344
        • Shulman N.B.
        • Ford C.E.
        • Hall W.D.
        • et al.
        Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program.
        Hypertension. 1989; 13: I80-I93
        • Matsushita K.
        • van der Velde M.
        • Astor B.C.
        • et al.
        • Chronic Kidney Disease Prognosis Consortium
        Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
        Lancet. 2010; 375: 2073-2081
        • Di Angelantonio E.
        • Chowdhury R.
        • Sarwar N.
        • et al.
        Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study.
        BMJ. 2010; 341: c4986
        • Chobanian A.
        • Bakris G.L.
        • Black H.R.
        • et al.
        The seventh report of the joint National committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report.
        JAMA. 2003; 289: 2560-2572
        • Mancia G.
        • De Backer G.
        • Dominiczak A.
        • et al.
        2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
        J Hypertens. 2007; 25: 1105-1187
        • Ruilope L.M.
        • van Veldhuisen D.J.
        • Ritz E.
        • et al.
        Renal function: the Cinderella of cardiovascular risk profile.
        J Am Coll Cardiol. 2001; 38: 1782-1787
        • Ruilope L.M.
        • Rodicio J.L.
        Microalbuminuria in clinical practice.
        Kidney Curr Surv World Lit. 1995; : 211-216
        • Brantsma A.H.
        • Bakker S.J.
        • de Zeeuw D.
        • et al.
        • PREVEND Study Group
        Extended prognostic value of urinary albumin excretion for cardiovascular events.
        J Am Soc Nephrol. 2008; 19: 1785-1791
        • Warnock D.G.
        • Muntner P.
        • McCullough P.A.
        • et al.
        • REGARDS investigators
        Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study.
        Am J Kidney Dis. 2010; 56: 861-871
        • Segura J.
        • Ruilope L.M.
        • Rodicio J.L.
        Microalbuminuria.
        Clin Exp Hypertens. 2004; 26: 701-707
        • Weir M.R.
        Microalbuminuria and cardiovascular disease.
        Clin J Am Soc Nephrol. 2007; 2: 581-590
        • Freedman B.I.
        • Kopp J.B.
        • Winkler C.A.
        • et al.
        Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.
        Am J Nephrol. 2009; 29: 626-632
        • Genovese G.
        • Friedman D.J.
        • Ross M.D.
        • et al.
        Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
        Science. 2010; 13: 841-845
        • Kidney Disease Outcomes Quality Initiative (K/DOQI)
        K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.
        Am J Kidney Dis. 2004; 43: S1-S290
        • Mancia G.
        • Laurent S.
        • Agabiti-Rosei E.
        • et al.
        Reappraisal of European guidelines on hypertension management: a European society hypertension task force document.
        J Hypertens. 2009; 27: 2121-2158
        • Appel L.J.
        • Wright Jr., J.T.
        • Greene T.
        • et al.
        • AASK collaborative research group
        Intensive blood-pressure control in hypertensive chronic kidney disease.
        N Engl J Med. 2010; 363: 918-929
        • Segura J.
        • Campo C.
        • Rodicio J.L.
        • et al.
        ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis.
        Hypertension. 2001; 38: 645-649